Related Experiment Video
Updated: Jun 20, 2026

04:34
Surgical Treatment of an Endolymphatic Sac Tumor
Published on: May 26, 2023
DEK::AFF2 Fusion-Associated Nonkeratinizing Squamous Cell Carcinoma with Noncontiguous Middle Ear and Sinonasal
Yan Li1, Linxiang Ma2, Wenlin Yang3
1Department of Pathology, Affiliated Hospital of Jining Medical University, Jining, 272029, Shandong, People's Republic of China.
Head and Neck Pathology
|June 19, 2026
Summary
This case highlights DEK::AFF2 fusion-associated nonkeratinizing squamous cell carcinoma in the middle ear and sinonasal regions. Recognizing its unique features is crucial for accurate diagnosis and avoiding misinterpretation as benign conditions.
Area of Science:
- Oncology
- Pathology
- Genetics
Background:
- DEK::AFF2 fusion-associated nonkeratinizing squamous cell carcinoma (NSCC) is a rare, HPV-independent malignancy.
- This entity often presents with subtle morphologic features, mimicking benign or inflammatory conditions.
- Accurate diagnosis is challenging due to its deceptive appearance.
Purpose of the Study:
- To report a case of DEK::AFF2 fusion-associated NSCC involving noncontiguous middle ear and sinonasal sites.
- To detail the clinicopathologic, immunophenotypic, and molecular characteristics of this rare tumor.
- To emphasize the importance of recognizing this entity to prevent misdiagnosis.
Main Methods:
- Case presentation of a 21-year-old female with recurrent otorrhea and hearing loss.
- Radiologic imaging revealed noncontiguous lesions in the middle ear/mastoid and sinonasal regions.
- Histopathological examination, immunohistochemistry (CK5/6, p40, p53, p16, INSM1, AFF2), and targeted next-generation sequencing were performed.
Main Results:
- Both lesions exhibited nonkeratinizing squamous proliferation with focal papillary/inverted architecture, mild atypia, and stromal invasion.
- Immunohistochemistry showed diffuse nuclear AFF2, CK5/6+, p40+, wild-type p53, p16-, and INSM1-.
- DEK::AFF2 fusion was confirmed in both tumor sites via next-generation sequencing.
Conclusions:
- This case expands the known anatomical distribution of DEK::AFF2 fusion-associated NSCC to include the middle ear and sinonasal regions.
- The findings underscore the need for a high index of suspicion for this entity in relevant clinical scenarios.
- Comprehensive evaluation including molecular testing is essential for definitive diagnosis and appropriate management.
